Yu (Andrew) Wang

andrew.wang@lw.com

+1.617.880.4665

Profile

Andrew Wang is an associate in the Boston office of Latham & Watkins.

Andrew earned his JD from Columbia Law School. While in law school, Andrew served as a legal extern at the United Nations, advocating for marine biomass and environmental awareness.

Prior to law school, Andrew held various research and business front-end positions in the life science industry.

Qualifications

Bar Qualification

Massachusetts

Education

JD, Columbia Law School, 2025
MS in Biotechnology, Northwestern University, 2018
BS in Biotechnology, Jiangnan University, 2016

Languages Spoken

English
Chinese (Mandarin)
Chinese (Shanghainese)

September 21, 2026 Our Work

Latham & Watkins Advises on Halozyme Therapeutics, Inc.’s Upsized US$1.3 Billion Convertible Senior Notes Offering

Multidisciplinary team represents the initial purchasers in the offering by the biopharmaceutical company.

Close-up of abstract molecular structure.

September 18, 2026 Our Work

Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering

Firm represents underwriters in the late clinical-stage biopharmaceutical company’s IPO.

Close-up of scientist examining slide under a microscope.

September 15, 2026 Our Work

Latham Advises GSK on Agreement to Acquire a Potential Best-in-Class Trispecific T Cell-Engager

Firm represents the global biopharma company in the transaction.